Literature DB >> 26202234

Transcriptional Profiling of the Immune Response to Marburg Virus Infection.

John H Connor1, Judy Yen2, Ignacio S Caballero2, Sara Garamszegi2, Shikha Malhotra2, Kenny Lin3, Lisa Hensley3, Arthur J Goff3.   

Abstract

UNLABELLED: Marburg virus is a genetically simple RNA virus that causes a severe hemorrhagic fever in humans and nonhuman primates. The mechanism of pathogenesis of the infection is not well understood, but it is well accepted that pathogenesis is appreciably driven by a hyperactive immune response. To better understand the overall response to Marburg virus challenge, we undertook a transcriptomic analysis of immune cells circulating in the blood following aerosol exposure of rhesus macaques to a lethal dose of Marburg virus. Using two-color microarrays, we analyzed the transcriptomes of peripheral blood mononuclear cells that were collected throughout the course of infection from 1 to 9 days postexposure, representing the full course of the infection. The response followed a 3-stage induction (early infection, 1 to 3 days postexposure; midinfection, 5 days postexposure; late infection, 7 to 9 days postexposure) that was led by a robust innate immune response. The host response to aerosolized Marburg virus was evident at 1 day postexposure. Analysis of cytokine transcripts that were overexpressed during infection indicated that previously unanalyzed cytokines are likely induced in response to exposure to Marburg virus and further suggested that the early immune response is skewed toward a Th2 response that would hamper the development of an effective antiviral immune response early in disease. Late infection events included the upregulation of coagulation-associated factors. These findings demonstrate very early host responses to Marburg virus infection and provide a rich data set for identification of factors expressed throughout the course of infection that can be investigated as markers of infection and targets for therapy. IMPORTANCE: Marburg virus causes a severe infection that is associated with high mortality and hemorrhage. The disease is associated with an immune response that contributes to the lethality of the disease. In this study, we investigated how the immune cells circulating in the blood of infected primates respond following exposure to Marburg virus. Our results show that there are three discernible stages of response to infection that correlate with presymptomatic, early, and late symptomatic stages of infection, a response format similar to that seen following challenge with other hemorrhagic fever viruses. In contrast to the ability of the virus to block innate immune signaling in vitro, the earliest and most sustained response is an interferon-like response. Our analysis also identifies a number of cytokines that are transcriptionally upregulated during late stages of infection and suggest that there is a Th2-skewed response to infection. When correlated with companion data describing the animal model from which our samples were collected, our results suggest that the innate immune response may contribute to overall pathogenesis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202234      PMCID: PMC4577901          DOI: 10.1128/JVI.01142-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.

Authors:  Judy Y Yen; Sara Garamszegi; Joan B Geisbert; Kathleen H Rubins; Thomas W Geisbert; Anna Honko; Yu Xia; John H Connor; Lisa E Hensley
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007.

Authors:  Jennifer Adjemian; Eileen C Farnon; Florimond Tschioko; Joseph F Wamala; Emmanuel Byaruhanga; Godfrey S Bwire; Edgar Kansiime; Atek Kagirita; Sam Ahimbisibwe; F Katunguka; Ben Jeffs; Julius J Lutwama; Robert Downing; Jordan W Tappero; Pierre Formenty; Brian Amman; Craig Manning; Jonathan Towner; Stuart T Nichol; Pierre E Rollin
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.

Authors:  Aimee K Zaas; Minhua Chen; Jay Varkey; Timothy Veldman; Alfred O Hero; Joseph Lucas; Yongsheng Huang; Ronald Turner; Anthony Gilbert; Robert Lambkin-Williams; N Christine Øien; Bradly Nicholson; Stephen Kingsmore; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg
Journal:  Cell Host Microbe       Date:  2009-08-06       Impact factor: 21.023

4.  Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression.

Authors:  Victoria Wahl-Jensen; Sabine Kurz; Friedericke Feldmann; Lukas K Buehler; Jason Kindrachuk; Victor DeFilippis; Jean da Silva Correia; Klaus Früh; Jens H Kuhn; Dennis R Burton; Heinz Feldmann
Journal:  PLoS Negl Trop Dis       Date:  2011-10-18

5.  Retrospective evaluation of control measures for contacts of patient with Marburg hemorrhagic fever.

Authors:  Aura Timen; Leslie D Isken; Patricia Willemse; Franchette van den Berkmortel; Marion P G Koopmans; Danielle E C van Oudheusden; Chantal P Bleeker-Rovers; Annemarie E Brouwer; Richard P T M Grol; Marlies E J L Hulscher; Jaap T van Dissel
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

Review 6.  Mouse models for filovirus infections.

Authors:  Steven B Bradfute; Kelly L Warfield; Mike Bray
Journal:  Viruses       Date:  2012-09-07       Impact factor: 5.048

7.  A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2.

Authors:  Christopher W Woods; Micah T McClain; Minhua Chen; Aimee K Zaas; Bradly P Nicholson; Jay Varkey; Timothy Veldman; Stephen F Kingsmore; Yongsheng Huang; Robert Lambkin-Williams; Anthony G Gilbert; Alfred O Hero; Elizabeth Ramsburg; Seth Glickman; Joseph E Lucas; Lawrence Carin; Geoffrey S Ginsburg
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

8.  Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure.

Authors:  Shikha Malhotra; Judy Y Yen; Anna N Honko; Sara Garamszegi; Ignacio S Caballero; Joshua C Johnson; Eric M Mucker; John C Trefry; Lisa E Hensley; John H Connor
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

Review 9.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

10.  The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.

Authors:  Kathleen H Rubins; Lisa E Hensley; Victoria Wahl-Jensen; Kathleen M Daddario DiCaprio; Howard A Young; Douglas S Reed; Peter B Jahrling; Patrick O Brown; David A Relman; Thomas W Geisbert
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  20 in total

1.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans.

Authors:  Emily Speranza; Paula Ruibal; Julia R Port; Feng Feng; Lia Burkhardt; Adam Grundhoff; Stephan Günther; Lisa Oestereich; Julian A Hiscox; John H Connor; César Muñoz-Fontela
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 3.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

4.  Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques.

Authors:  Kenny L Lin; Nancy A Twenhafel; John H Connor; Kathleen A Cashman; Joshua D Shamblin; Ginger C Donnelly; Heather L Esham; Carly B Wlazlowski; Joshua C Johnson; Anna N Honko; Miriam A Botto; Judy Yen; Lisa E Hensley; Arthur J Goff
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  Dimerization Controls Marburg Virus VP24-dependent Modulation of Host Antioxidative Stress Responses.

Authors:  Britney Johnson; Jing Li; Jagat Adhikari; Megan R Edwards; Hao Zhang; Toni Schwarz; Daisy W Leung; Christopher F Basler; Michael L Gross; Gaya K Amarasinghe
Journal:  J Mol Biol       Date:  2016-08-04       Impact factor: 5.469

6.  Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner.

Authors:  Adam Hume; Elke Mühlberger
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 7.  The Role of Cytokines and Chemokines in Filovirus Infection.

Authors:  Sandra L Bixler; Arthur J Goff
Journal:  Viruses       Date:  2015-10-23       Impact factor: 5.048

8.  The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.

Authors:  Ndongala Michel Lubaki; Patrick Younan; Rodrigo I Santos; Michelle Meyer; Mathieu Iampietro; Richard A Koup; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2016-12-08       Impact factor: 6.823

9.  In vivo Ebola virus infection leads to a strong innate response in circulating immune cells.

Authors:  Ignacio S Caballero; Anna N Honko; Stephen K Gire; Sarah M Winnicki; Marta Melé; Chiara Gerhardinger; Aaron E Lin; John L Rinn; Pardis C Sabeti; Lisa E Hensley; John H Connor
Journal:  BMC Genomics       Date:  2016-09-05       Impact factor: 3.969

10.  A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.

Authors:  Andrea Marzi; Logan Banadyga; Elaine Haddock; Tina Thomas; Kui Shen; Eva J Horne; Dana P Scott; Heinz Feldmann; Hideki Ebihara
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.